Non-adherence to antimicrobial stewardship prospective audit and feedback advice: Risk factors and clinical consequences

Christopher D. Horton, Matthew D.M. Rawlins, Laurens Manning, Paul R. Ingram

Research output: Contribution to journalArticle

Abstract

Amongst 325 patients receiving restricted antimicrobials whose management was subject to antimicrobial stewardship prospective audit and feedback, adherence to advice was 78%. Non-adherence was associated with diabetic patients, giving more than 1 piece of advice and receipt of piperacillin/tazobactam therapy, and was inversely associated with liver disease. Adherence to advice was associated with a one third reduction in duration of antimicrobial use without adversely impacting other infection-related patient outcomes.

Original languageEnglish
Pages (from-to)485-488
Number of pages4
JournalJournal of Infection and Chemotherapy
Volume25
Issue number6
DOIs
Publication statusPublished - 1 Jun 2019

Fingerprint

Liver Diseases
Infection
Therapeutics
tazobactam drug combination piperacillin

Cite this

@article{5724f942ca3b43759fbcd5e65a948b23,
title = "Non-adherence to antimicrobial stewardship prospective audit and feedback advice: Risk factors and clinical consequences",
abstract = "Amongst 325 patients receiving restricted antimicrobials whose management was subject to antimicrobial stewardship prospective audit and feedback, adherence to advice was 78{\%}. Non-adherence was associated with diabetic patients, giving more than 1 piece of advice and receipt of piperacillin/tazobactam therapy, and was inversely associated with liver disease. Adherence to advice was associated with a one third reduction in duration of antimicrobial use without adversely impacting other infection-related patient outcomes.",
keywords = "Adherence, Antimicrobial, Antimicrobial stewardship, Infectious diseases, Prospective audit and feedback",
author = "Horton, {Christopher D.} and Rawlins, {Matthew D.M.} and Laurens Manning and Ingram, {Paul R.}",
year = "2019",
month = "6",
day = "1",
doi = "10.1016/j.jiac.2019.02.011",
language = "English",
volume = "25",
pages = "485--488",
journal = "Journal of Infection and Chemotherapy",
issn = "1341-321X",
publisher = "Elsevier",
number = "6",

}

Non-adherence to antimicrobial stewardship prospective audit and feedback advice : Risk factors and clinical consequences. / Horton, Christopher D.; Rawlins, Matthew D.M.; Manning, Laurens; Ingram, Paul R.

In: Journal of Infection and Chemotherapy, Vol. 25, No. 6, 01.06.2019, p. 485-488.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Non-adherence to antimicrobial stewardship prospective audit and feedback advice

T2 - Risk factors and clinical consequences

AU - Horton, Christopher D.

AU - Rawlins, Matthew D.M.

AU - Manning, Laurens

AU - Ingram, Paul R.

PY - 2019/6/1

Y1 - 2019/6/1

N2 - Amongst 325 patients receiving restricted antimicrobials whose management was subject to antimicrobial stewardship prospective audit and feedback, adherence to advice was 78%. Non-adherence was associated with diabetic patients, giving more than 1 piece of advice and receipt of piperacillin/tazobactam therapy, and was inversely associated with liver disease. Adherence to advice was associated with a one third reduction in duration of antimicrobial use without adversely impacting other infection-related patient outcomes.

AB - Amongst 325 patients receiving restricted antimicrobials whose management was subject to antimicrobial stewardship prospective audit and feedback, adherence to advice was 78%. Non-adherence was associated with diabetic patients, giving more than 1 piece of advice and receipt of piperacillin/tazobactam therapy, and was inversely associated with liver disease. Adherence to advice was associated with a one third reduction in duration of antimicrobial use without adversely impacting other infection-related patient outcomes.

KW - Adherence

KW - Antimicrobial

KW - Antimicrobial stewardship

KW - Infectious diseases

KW - Prospective audit and feedback

UR - http://www.scopus.com/inward/record.url?scp=85063106949&partnerID=8YFLogxK

U2 - 10.1016/j.jiac.2019.02.011

DO - 10.1016/j.jiac.2019.02.011

M3 - Article

VL - 25

SP - 485

EP - 488

JO - Journal of Infection and Chemotherapy

JF - Journal of Infection and Chemotherapy

SN - 1341-321X

IS - 6

ER -